Psychosomatic Medicine Conferences | Psychiatry Conferences | Mental Health Conferences | Psychiatry Disorders Conferences | Psychology Meetings | Psychotherapy Events | Depression Conference | Neuropsychiatry and Neuroscience Conference | Rome | Italy | Europe | USA | Asia Pacific | Middle East

Theme:

Psychosomatic Medicine 2020

Conference program

Renowned Speakers

Jouko Miettunen
University of Oulu
Finland

Verena Hein
American Psychological Association
USA

Gregory P Brown
University of Nevada Las Vegas School of Medicine
USA

Marie Conception Leocadie
Sorbonne Paris City University
France

Khurram Sadiq
Greater Manchester Mental Health NHS Foundation Trust
UK

Adrian Low
California Southern University
USA

Annamarie Paulsen
Rockdale Psychiatric Associates
USA

Fagogenis Gerasimos
Athens University School of Medicine
Greece

Paolo Scapellato
European University of Rome
Italy

Harry G. Segal
Cornell University & Weill Cornell Medical School
USA

Theodore Bender
Addiction Campus, USA Panel Discussion
USA

Anna Nakamura
University of Tokyo
Japan

Agneta Schroder
Orebro University
Sweden

Eleonora Papaleontiou
European University
Cyprus

Debra Coleman
California Baptist University
USA

Jennifer L Fee
Vanguard University
USA

Satu Pihlaja
University of Helsinki
Finland

Karina Blancarte Figueroa
International University of Professional Studies
Mexico

Gisele Fernandes
California Institute of Integral Studies
USA

Lissy Ann Puno
International Counseling and Psychology Centre,
Singapore

Carol Rose Adkisson
The Trauma and Healing Foundation
USA

Stephenson W Nkinin
University of Cincinnati
USA

Felice Carabellese
University of Bari
Italy

Merin thomas
All India Institute of Medical Sciences
India

Natalia Sypion-Dutkowska
University of Szczecin
Poland

Larry E. Britton
The Chicago School of Professional Psychology
USA

Mag. Ruth-Pauline Wachter
iGumps
Austria

Bob Reese
Jefferson College of Health Sciences
USA

Sai Charan P G
SDM College of Medical Sciences and Hospital
India

Gemma Hamilton
RMIT University
Australia

Karin E. Peuschel
Praxis Erlenhof
Switzerland

Norris Wise
The Chicago School of Professional Psychology
USA

Merve Topcu
Cankaya University
Turkey

Psychosomatic Medicine 2020

On behalf of Organizing Committee we cordially welcomes all the participants and contributors from worldwide to attend 26^th International Conference on Psychiatry, Mental Disorders and Psychosomatic Medicine which is going to be held in Amsterdam, Netherlands during October 21-22, 2020 across the theme “Exploring Innovative Therapies to Achieve Mental and Physical Wellness”.

We invite you to join us at Psychiatry, Mental Disorders and Psychosomatic Medicine Conference where you will be sure to have a meaningful experience with scholars from around the world. Generous response and active participation from the Editorial Board Members of conference related Journals as well as from the scientists, researchers and leaders in the field of will make this conference as one of the most successful and productive events in 2019.

We continue to have significant problems with Negativity, drug abuse, depression, Organizational pressure, and psychological well-being. As the world grappling under so much stress and negativity, the light of positive psychology is the only hope at the end of the tunnel. Psychosomatic Medicine is the emerging field which adds significant dynamism into the psychology world.

The Psychosomatic Medicine 2020 is a unique platform for a focused plan of the current research in the field of variety of advanced research topics including Psychopharmacology, Psychiatry Disorders, Psychology, Psychotherapy, Neurodegenerative Disorders, Psychosomatic medicines, Mental Health & Wellness, Dementia, Obsessive Compulsive Disorders, Psychosomatic Treatment, Mental Health Nursing experiences of various treatment procedures.

Psychiatry, Mental Disorders and Psychosomatic Medicine Conference includes prompt keynote presentations, oral talks, poster presentations, delegate views, board talks, workshop and exhibitions. Join us for two intensive and interesting days of discussing contemporary challenges and new advancements in recovery of mental disorders through psychosomatic medicines and therapies. We invite you to contribute and help to shape the event through submissions of your research abstracts, papers and e-posters. Also, high quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or theoretical work in all areas of Psychiatry Disorders and Psychosomatic Medicine are cordially invited for presentation at the conference.

Psychosomatic Medicine 2020 is the leading meeting dedicated to Psychiatrists and Psychologists to share their expertise, inferences and recent advancement in their research work on the direction of psychological well-being and happiness in the world. We are gratified to invite all the participants from all part of the world to attend the Psychosomatic Medicine Conferences entitled "26^th International Conference on Psychiatry, Mental disorders and Psychosomatic Medicine" scheduled during October 21-22, 2020 at Amsterdam, Netherlands.

Objective:

Establishing the professional network.
Creating contacts to provide a means for scientific and industrial exchanges.
Boosting the scientific research with other scientific professionals in the country and throughout the world.
Strengthening the network between the university and other related industries.
Summarize the studies of Psychiatry, Mental Disorders and Psychosomatic Medicine.
Discussing the latest findings and achievements in the treatment of Mental Disorders and Wellbeing.

Target Audience:

Psychologists, Psychiatrists, Neuropsychiatrists, Psychotherapists
Nurse Practitioners
Professors, Associate Professors, Assistant Professors
Ph.D. Scholars
Directors, CEO’s of Organizations
Association Presidents, Vice Presidents, and Professionals
Noble laureates in Health Care and Medicine
Pharmaceutical development companies
Research Institutes and members
Graduates and Postgraduates
Medical devices Manufacturing Companies
Training Institutes
Business Entrepreneurs

Participation Benefits:

Accepted abstracts will be published in the respective International supporting Journals
Each abstract will receive a (DOI) Number provided by Cross-Ref
All attendees will receive individual certification
Access to all sessions
Special privileges on group registrations
Best Poster Award
Avail the opportunity to organize pre-conference/conference workshop
Symposiums on latest research
Handbook and conference kit
60% discount on manuscript publication

For Women Scholars

Offering 20% discount to Women Participants as a special appreciation to
Women in Science & Technology

Registration Prices in EURO

REGISTRATION CATEGORIES	ACTUAL PRICE (in Euro)	AFTER 20% DISCOUNT (in Euro)
Speaker- Academic	€650	€520
Package-A	€870	€696
Package-B	€980	€784

To avail the discount offers follow the below:

1. Visit the website: https://psychosomaticmedicine.conferenceseries.com/registration.php

2. Chose the currency as Euro

3. Fill in the details as sought

4. Type of Registration: As applicable

5. Chosen Price: Enter the discounted price in the above table

Note: Registration shall stand valid only to women participants.

Track 1: Psychiatry

Psychiatry is the therapeutic claim devoted to the finding, avoidance, study, and treatment of the mental issue. Psychiatry is the principal branch of solution concentrated on the analysis, treatment, and anticipation of mental, passionate and behavioural scatters. These abnormalities identified with mood, behaviour, cognizance, and observations. Beginning mental evaluation of a person regularly starts with a case history and mental status examination.

Europe and UK: European Mental Health Association, European Psychiatric Association, European Association of Social Psychology, European Association of Psychosomatic Medicine, The British Psychological Society, European Association of Work and Organizational Psychology, European Academy of Occupational Health Psychology, British Association for Behavioural and Cognitive Psychotherapies, Finnish Psychological Association, Psychological Society of Ireland, Russian Psychological Society, Turkish Psychological Association.

Asia and Middle East: Asian Association of Social Psychology, Asian Cognitive Behavioural Therapy Association, The Australian Psychological Society, Chinese Psychological Society, New Zealand Association of Positive Psychology, New Zealand Psychological Society, Indian Association of Positive Psychology, Hong Kong Psychological Society, Indian Psychological Association, Society of Australasian Social Psychologists, Israel Psychological Association, The Middle East Psychological Association, Emirates Psychological Association, Japanese Society of Psychosomatic Medicine, Japanese Society of Behavioural Medicine.

Track 2: Psychosomatic Medicine

Psychosomatic medicine is a newly licensed subspecialty in the field of psychiatry; it is also known as consultation-liaison psychiatry. C-L psychiatry provides knowledge, practice, and instruction in the relation between mental and physical illness. This field is associated with services like diagnosis, therapeutics and research of illnesses in this area. Hence it connects psychiatry and other medical specialties, so that physicians and psychiatrists can discuss how to best manage patients with psychosomatic illness.

Track 3: Child and Adolescent Psychiatry

Child and Adolescent Psychiatry is a multidisciplinary scholarly periodical that encourages research on the diagnosis, treatment, and prevention of mental disorders in children, adolescents, and their families. It investigates the biopsychosocial factors that influence the development and course of these psychiatric disorders and treatment responses to various interventions. It mainly focuses on developmental disorders (Autism spectrum disorder), Disorders of Attention and Behaviour, Psychotic Disorders, Mood Disorders, Anxiety Disorders, Eating Disorders and Gender Identity Disorder.

Track 4: Drug abuse and Addiction

Drug abuse is a serious public health problem that affects almost every community and family in some way. You may abuse drugs to feel good, ease stress, or avoid reality. But usually, you’re able to change your unhealthy habits or stop using altogether. Drug addiction isn’t about just heroin, cocaine, or other illegal drugs. You can get addicted to alcohol, nicotine, opioid painkillers, and other legal substances. This may contain disorders including legal and illegal drugs, gambling, sex, and other impulse control disorders. Addiction psychiatrists are substance abuse experts. Growing amount of scientific knowledge, such as the health effects and treatments to substance abuse, has led to advancements in the field of addiction psychiatry.

Track 5: Psychosomatic Disorders

Psychosomatic Disorders is a condition in which psychological stresses adversely affect physiological (somatic) functioning to the point of distress. It is a condition of dysfunction or structural damage in bodily organs through inappropriate activation of the involuntary nervous system and the glands of internal secretion. Psychosomatic disorders resulting from stress may include hypertension, respiratory ailments, gastrointestinal disturbances, migraine and tension headaches, pelvic pain, impotence, frigidity, dermatitis, and ulcers.

Track 6: Psychotherapy

Psychotherapy is a way to help people with a broad variety of mental illnesses and emotional difficulties. Psychotherapy can help eliminate or control troubling symptoms, so a person can function better and can increase well-being and healing. Psychotherapy is a general term for treating mental health problems by talking with a psychiatrist, psychologist or other mental health providers.

Track 7: Cognitive Behavioral Therapy

Cognitive behavioral therapy (CBT) is a short-term, goal-oriented psychotherapy treatment that takes a hands-on, practical approach to problem-solving. Its goal is to change patterns of thinking or behavior that are behind people’s difficulties, and so change the way they feel. It is used to help treat a wide range of issues in a person’s life, from sleeping difficulties or relationship problems to drug and alcohol abuse or anxiety and depression.

Track 8: Alzheimer’s and Dementia

Alzheimer's is a type of dementia that causes problems with memory, thinking and behaviour. Dementia is the loss of cognitive functioning—thinking, remembering, and reasoning—and behavioural abilities to such an extent that it interferes with a person's daily life and activities. These functions include memory, language skills, visual perception, problem-solving, self-management, and the ability to focus and pay attention. Some people with dementia cannot control their emotions, and their personalities may change. The rate at which the disease progresses is different for everyone, but on average, people with Alzheimer’s live for eight years after symptoms begin. While there are currently no treatments to stop Alzheimer’s disease from progressing, there are medications to treat dementia symptoms.

Track 9: Psychopharmacology

Psychopharmacology is demarcated as a scientific study that deals with the influence of medicines have on mood, perception, discerning, and activities. Psychopharmacology is differentiated from Neuropsychopharmacology that highlights the relationship between drug made changes within the working. Psychoactive drugs relate mainly with specific receptors or target sites found in the nervous system to persuade a pervasive change of cells within the nervous system and alters the consciousness and behavioural changes in psychological or physiological functions.

Track 10: Mental Health and Wellness

Emotional wellness is characterized as a condition of prosperity in which each individual understands his or her own potential, can adapt to the typical worries of life, can work gainfully and productively, and can make a commitment to her or his group. Emotional well-being impacts every single one of us. We have emotional well-being, similarly as we have physical wellbeing. Individuals living with an emotional well-being issue or condition can encounter positive psychological well-being, and an individual may encounter poor emotional wellness without a psychological wellness condition.

Track 11: Telepsychiatry

Telepsychiatry is the application of telemedicine to the specialty field of psychiatry. The term typically describes the delivery of psychiatric assessment and care through video conferencing. Telepsychiatry services can be offered through intermediary companies that partner with facilities to increase care capacities, or by individual providers or provider groups. Most commonly, telepsychiatry encounters take place at medical facilities under the supervision of onsite staff, though at-home models are becoming accepted if they are in compliance with HIPAA standards.

Track 12: Psychology

Psychology is the branch of science which deals with the science of mind and behavior. It studies with the mental and behavioral characteristics of an individual or a group and gives solution for many complex aspects. Psychology is a challenging discipline and it includes many sub-fields. The professional practitioner is called Psychologist and the research works carried is of great values as it covers the social issues.

Track 13: Behavioural Science & Medicine

Behavioural science is the systematic analysis of human behaviour through experiments and observations. Observation and experiments are the two main sources of Behavioural Science. Behavioural medicine is the interdisciplinary field concerned with the development and integration of behavioural, psychosocial, and biomedical science knowledge and techniques relevant to the understanding of health and illness, and the application of this knowledge and these techniques to prevention, diagnosis, treatment and rehabilitation.

Track 14: Neuropsychology and Neurodegenerative Disorders

Neuropsychology concerned with the applied science of brain-behavior relationships. This field incorporates principles of assessment and intervention based upon the scientific research of human behavior as it relates to the normal and abnormal functioning of the central nervous system. Neurodegenerative diseases are incurable and debilitating conditions that result in progressive degeneration and/or death of nerve cells. This causes problems with movement (called ataxias), or mental functioning (called dementias). Assessment includes neuropsychological tests, patient history, qualitative observation, neuroimaging, and diagnostic procedures.

Track 15: Women and Mental Health

Depression, anxiety, psychological distress, sexual violence, domestic violence and escalating rates of substance use affect women than men across different countries and different settings. Pressures created by their multiple roles, gender discrimination and associated factors of poverty, hunger, malnutrition, overwork, domestic violence, and sexual abuse, combine to account for women's poor mental health. When women dare to disclose their problems, many health workers tend to have gender biases which lead them to either over-treat or under-treat women.

Track 16: Bipolar Disorder and Schizophrenia

Bipolar disorder and schizophrenia are severe mental illnesses commonly referred to as psychotic disorders, meaning symptoms can include psychosis—impaired thoughts and emotions severe enough to induce a disconnect from reality. Bipolar disorder causes severe shifts in mood, ranging from depressive lows to manic highs. Schizophrenia is a chronic and severe mental health disorder that affects how a person thinks feels and behaves. People with schizophrenia may seem like they have lost touch with reality and can experience hallucinations, delusions, and disorganized thinking.

Track 17: Personality Disorders

Personality is the way of thinking, feeling and behaving that makes a person different from other people. A personality disorder is a way of thinking, feeling and behaving that deviates from the expectations of the culture, causes distress or problems functioning, and lasts over time. This causes significant problems and limitations in relationships, social activities, work, and school. An individual’s personality is influenced by experiences, environment (surroundings, life situations) and inherited characteristics.

Track 18: Anxiety, Stress, and Depression

Anxiety is a feeling described by an upsetting condition of inward disturbance, frequently accompanied by nervous behavior like pacing back and forth, substantial objections, and rumination. Anxiety is the desire of future threat. Depression is a condition of low mood and antipathy for a movement that can influence any one’s thoughts, behavior, tendencies, emotions, and feeling of prosperity. Stress, a type of mental agony is a feeling of strain and pressure. Stress can build the danger for strokes, heart attacks, ulcers, and depression.

Track 19: Sleep Disorders

Sleep disorders involve problems with the quality, timing and amount of sleep, which cause problems with functioning and distress during the daytime. Sleep difficulties are linked to both physical and emotional problems. Sleep problems can both contribute to or exacerbate mental health conditions and be a symptom of other mental health conditions.

Track 20: Obsessive Compulsive Disorder

Obsessive-compulsive disorder (OCD) is a mental health condition characterized by distressing, intrusive, obsessive thoughts and repetitive, compulsive physical or mental acts. The obsessions or compulsions cause marked distress, are time-consuming, and interfere with a person's normal function. Indications of OCD can occur in children and teenagers, with the disease usually beginning gradually and worsening with age. Symptoms of OCD can be mild or severe. Some people experience obsessive thoughts only, without engaging in compulsive behavior.

Track 21: Mental Health Nursing

Mental nursing or psychological well-being nursing is the selected position of a nursing that has represented considerable authority in emotional wellness and watches over individuals of any age with dysfunctional behaviour or mental trouble, for example, schizophrenia, bipolar turmoil, psychosis, gloom, dementia and some more.

Psychosomatic Medicine 2020, provides the participants with different modes or ways to participate under either ACADEMIC / STUDENT / BUSSINESS Category

SPEAKER (Oral Presentation): 25-30 minutes (only one person can present)
SPEAKER (Workshop): 45-50 minutes (more than 1 can present)
SPEAKER (Special Session): 45-50 minutes (more than 1 can present)
SPEAKER (Symposium): more than 45 minutes (more than 1 can present)
DELEGATE (only registration): Will have access to all the sessions with all the benefits of registration
POSTER PRESENTER: Can present a poster and avail the benefits of delegate
REMOTE ATTENDENCE: Can participate via VIDEO presentation or E-poster presentation
EXHIBITOR: Can exhibit his/her company’s products by booking exhibitor booths of different sizes
MEDIA PARTNER
SPONSOR
COLLABORATOR

For Researchers & Faculty:

Speaker Presentations
Poster Display
Symposium hosting
Workshop organizing

For Universities, Associations & Societies:

Association Partnering
Collaboration proposals
Group Participation

For Students & Research Scholars:

Poster Competition (Winner will get Best Poster Award)
Young Researcher Forum (YRF Award to the best presenter)
Student Attendee
Group Registrations

For Business Delegates:

Speaker Presentations
Symposium hosting
Book Launch event
Networking opportunities
Audience participation

For Companies:

Exhibitor and Vendor Booths
Sponsorships opportunities
Product launch
Workshop organizing
Scientific Partnering
Marketing and Networking with clients

For more details about each mode, kindly contact:

Eliza Brown (Program Director)

Importance & Scope:

Mental Illness or psychotherapeutic conditions are classified as abnormal thoughts, feelings, and behaviour, for a determined amount of time, which causes distress or emotional/physical impairment. This includes a wide range of psychological or psychiatric disorders and often requires psychiatric intervention. Conditions can be caused by either a biological origin such as genetic, chemical, and anatomical; or a psychological origin such as trauma or conflict. Extraordinary advances have been made in the treatment of mental illness. An understanding of what causes some mental health disorders has led to greater sophistication in tailoring treatment to the underlying basis of each disorder. As a result, many mental health disorders can now be treated nearly as successfully as physical disorders.

Most treatment methods for mental health disorders can be categorized as either somatic or psychotherapeutic. Somatic treatments include drug therapy and electroconvulsive therapy. Psychotherapeutic treatments include individual, group, or family and marital psychotherapy; behaviour therapy techniques (such as relaxation training or exposure therapy); and hypnotherapy. Most studies suggest that for major mental health disorders, a treatment approach involving both drugs and psychotherapy is more effective than either treatment method used alone. The psychotherapeutic drug industry continues to struggle through a morass of issues that are directly or indirectly affecting competition. Some hurdles recently faced by competitors in this market include advertising restrictions, label changes, and some general negative views about mental illness treatments. However, there have been considerable strides in many areas of the market including advanced delivery techniques, increased education and awareness efforts, and improved effectiveness.

Psychiatrists as well as psychosomatic committees assist people from all backgrounds and difficulties, to overcome depression, anger, anxiety. They also communicate people to survive with stressful situations, overcome addictions, improve their relationships with their husband, wife or parents, and break through barriers that keep people from reaching their potential. They also give psychological tests to evaluate cognitive strengths and weaknesses, personality characteristics, and more.

Mental Illness in Europe:

Mental health problems affect about 84 million people in the EU, according to the latest estimates from the Institute for Health Metrics and Evaluation. That’s more than one in six people facing problems that range from anxiety to depression to drug and alcohol addiction, as well as severe mental illnesses like bipolar or schizophrenic disorders.

Such problems come at a high personal and social cost. Across EU countries, over 84,000 people died due to mental health problems or by suicide in 2015. Add to this people with mental health problems who die prematurely from physical causes, such as untreated chronic diseases. The overall costs related to mental ill-health in the EU-28 are estimated to have exceeded 4% of GDP, or more than €600 billion, in 2015. This includes both direct spending on health systems and social security programmes, and indirect costs related to the likes of lower employment and lower productivity. These are also conservative estimates, as they do not consider social assistance or work-injury benefits, or the fact that the costs of treating a physical illness tend to be higher if the patient also has a mental illness. Impacts on carers and co-workers have not been included either.

Antidepressant Drugs Market Overview:

Depression includes a variety of mental health problems characterized by the absence of a positive emotion, low mood, and a range of associated cognitive, physical, emotional, and behavioural symptoms. It is a very common condition that affects 1 in every 5 Americans. There are many factors including genes, factors such as stress and brain chemistry that could lead to depression. According to WHO almost 350 million people worldwide were affected with depression in 2016. Antidepressants help maintain balance of various hormones and chemicals in the brain, which helps in the treatment of depression. The global antidepressant drugs market was valued at $13,755 million in 2016, and is estimated to reach $15,983 million by 2023, registering a CAGR of 2.1% from 2017 to 2023.

Increase in prevalence of depression, rise in geriatric population, and emergence of novel techniques for the development of drugs with fewer side-effects drive the market. Moreover, increase in awareness regarding the disease state and required clinical needs, and rise in number of people suffering from stress can fuel the growth of the antidepressant drugs market. However, poor efficacy and safety profiles of the drug, preference for non-pharmacological therapies, and increase in number of patent expiration of antidepressants that lead to weak pipeline are expected to hamper the market growth.

Why to attend?

We strive to make Psychosomatic Medicine Congress 2019 a success, with your support and high quality talks from both Psychiatrists as well as Psychological committees. During the conference, we assure you that you will experience world class facilities and hospitality at the conference.

26th International Conference on Psychiatry, Mental Disorders & Psychosomatic Medicine is a unique forum to bring together worldwide distinguished academics in the field of Psychology and Psychiatry, Psychosomatic Medicine researchers, public health professionals, scientists, academic scientists, industry researchers, scholars to exchange about state of the art research and technologies. The Conference will feature many exciting academic programs including multiple panels, workshops, affinity group lunches, paper presentations, and scientific sessions by reputed psychiatrists from all over the country.

Why Rome:

Rome is one of the best cities to organize an 26^th International Conference on Psychiatry, Mental Disorders and Psychosomatic Medicine. The research work going on in the field is in a good range when compared to the other cities. Rome is the fastest growing city in Italy with excellent economic growth.

Rome is a nationwide and major international centre for higher education, containing numerous academies, colleges, and universities. Rome today is one of the most important tourist destinations of the world, due to the incalculable immensity of its archaeological and artistic treasures, as well as for the charm of its unique traditions, the beauty of its panoramic views, and the majesty of its magnificent "villas" (parks). Rome's architecture over the centuries has greatly developed, especially from the Classical and Imperial Roman styles to modern Fascist architecture.

Rome is unique in that science as a resource is available to industrial companies in a highly compact manner and offers companies excellent cooperation opportunities. Rome is Italy’s top tourist city destination. It is a great city to visit, mixing venues of historical interest with exciting recreation and entertainment opportunities. Alongside its major historical sites, Rome offers a diverse range of top attractions – world-famous buildings, museums, city parks, cabaret theatres, festivals and of course plenty of shopping opportunities.

Psychosomatic Medicine 2020 at Rome will certainly give a wonderful experience to attendees to explore the beautiful city with gaining knowledge.

Conference Highlights:

· Psychiatry

· Psychiatric Disorder

· Psychosomatic Medicine

· Psychosomatic Disorders

· Psychodynamics

. Stress, Depression and Anxiety Disorders

. Addiction Psychiatry

. Schizophrenia

. Behavioural Sciences

. Clinical and Health Psychology

. Psychoneuroimmunology

. Neuropsychiatry

. Psychopathology

. Case Report

A Unique Opportunity for Advertisers and Sponsors at this International event:

https://psychosomaticmedicine.conferenceseries.com/sponsors.php

Major Associations around the Globe

. American Psychological Association

. Association for Psychological Science

. Australian Psychological Society

. British Psychological Association

. Danish Psychological Association

. Dutch Association of Psychologists

. Federation of German Psychologists’ Associations

. Korean Psychological Association

. Spanish Psychological Association

. Swedish Psychological Association

Around 500 top universities globally working in the field of Psychiatry and Neuroscience

. Dalhousie University

. Harvard University

. Massachusetts Institute of Technology

. New York University

. Stanford University

. University of Amsterdam

. University of Cambridge

. University of Oxford

. University of California, Berkeley

. University of California, Los Angeles

. University College London

. University of Queensland, Australia

. Yale University, USA

All around the Globe, there are 6000 hospitals working on Neurology

. Johns Hopkins Hospital

. World Brain Center Hospital

. Duke University Hospital

. Edward Hospital

. Munson Medical Center

Universities associated with Clinical Psychology around the globe:

For psychiatry, there are more than 250 universities all over the globe,

The top 5 universities are:

· Harvard University

· University of Cambridge

· Stanford University

· University of Oxford

· University of California, Berkeley

Companies Associated with Psychology in Japan are

Hospitals in USA related to Clinical Psychology are:

· Presbyterian University Hospital of Columbia and Cornell

· Massachusetts General Hospital

· Johns Hopkins Hospital

· McLean Hospital

· Menninger Clinic

· Sheppard and Enoch Pratt Hospital

· Resnick Neuropsychiatric Hospital at UCLA

· Mayo Clinic

· Yale-New Haven Hospital

· UPMC-University of Pittsburgh Medical Centre

Hospitals associated with Clinical Psychology around the globe:

There are about more than 10,000 psychiatric hospitals and asylum all over the world.

Most renowned psychiatric hospitals are

· New York- Presbyterian university Hospital of Columbia and Cornell

· Boston- Massachusetts General Hospital

· Baltimore- Johns Hopkins Hospitals

· Belmont- Mc Lean Hospitals

· Houston- Menninger Clinic

· Baltimore- Sheppard and Enoch Pratt Hospital

· Los Angeles- Resnick Neuropsychiatric Hospital at UCLA

· Pittsburgh- UPMC- University of Pittsburgh Medical Centre

· New Haven- Yale- New Haven hospital

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	October 21-22, 2020
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View

Useful Links

Special Issues

All accepted abstracts will be published in respective Our International Journals.

Abstracts will be provided with Digital Object Identifier by

26^th International Conference on Psychiatry, Mental Disorders & Psychosomatic Medicine October 21-22, 2020 Amsterdam, Netherlands

Recommended Global Psychiatry Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com